Home › Triple-Negative Breast Cancer › Florida › Miami
Triple-Negative Breast Cancer clinical trials in Miami, FL
11 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
- Sylvester Comprehensive Cancer Center, Miami
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
RecruitingPhase 1
- Biogenix Molecular, LLC, Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- University of Miami, Miami
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
RecruitingPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RecruitingPhase 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
RecruitingPhase 2
- Miami Baptist Cancer Institute/, Miami
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RecruitingPhase 2
- Miami Cancer Institute at Baptist Health (Kendall), Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
RecruitingPhase 2
- Baptist Alliance - McI, Miami
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RecruitingPhase 2
- AP Medical Research, Miami
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN27 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO20 studies
- Arlington, VA20 studies
- Atlanta, GA19 studies
- Dallas, TX18 studies
- Columbus, OH16 studies
- Chicago, IL16 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Obesity27 studies
- Prostate Cancer27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Multiple Myeloma21 studies
- Lung Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.